Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial combines three things at once — a fecal microbiota transplant, a calorie-restricted diet, and semaglutide — so could you help me understand which part is considered experimental here, and what risks come specifically from adding the FMT to the other two approaches?
2. 2Since this trial is listed as 'not yet recruiting,' do you have a sense of when it might open, and whether waiting to see if I qualify would affect my current treatment for obesity and type 2 diabetes?
3. 3The trial is listed as Phase NA, which I don't fully understand — does that mean the safety profile of this combined approach is less established than a Phase 2 or Phase 3 trial, and how should that affect my decision about whether to consider it?
4. 4Semaglutide is already an approved medication I could potentially start now — would it make more sense for me to begin standard treatment right away rather than waiting for a trial that isn't open yet?
5. 5Since the main thing being measured is percent change in body weight, how does that fit with my personal health goals around my type 2 diabetes, and would my blood sugar control also be tracked closely throughout the study?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.